Share on StockTwits

ICU Medical, (NASDAQ:ICUI) announced its earnings results on Monday. The company reported $0.38 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.34 by $0.04, AnalystRatings.Net reports. The company had revenue of $78.70 million for the quarter, compared to the consensus estimate of $74.13 million.

In other ICU Medical, news, Director George A. Lopez sold 4,300 shares of the company’s stock on the open market in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $57.77, for a total value of $248,411.00. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Shares of ICU Medical, (NASDAQ:ICUI) traded up 0.73% on Monday, hitting $57.89. The stock had a trading volume of 179,360 shares. ICU Medical, has a 52-week low of $54.00 and a 52-week high of $74.93. The stock has a 50-day moving average of $59.87 and a 200-day moving average of $59.82. The company has a market cap of $880.4 million and a P/E ratio of 23.01.

ICU Medical, Inc is engaged in the development, manufacture and sale of medical devices used in infusion therapy, oncology and critical care applications.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.